The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment, the company said on Wednesday.

GSK PLC GSK shares rose 1.78% to £13.72 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.42% to 9,061.49. GSK PLC ...

Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.

The FDA oncologic drugs advisory committee voted against the approval of GSK’s blood cancer treatment Blenrep, delivering a setback to the drugmaker’s efforts to reintroduce the drug to the U.S.

London's main stock indexes rose on Friday, with the blue-chip index hovering near record highs, aided by a slew of positive ...

The FTSE 100 index of leading shares has broken through 9,000 for the first time. That’s not as impressive as it ...

Explore Matthews International Corporation's restructuring efforts, asset sales, and challenges in reducing debt. Click for ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine segment. See why the stock is a Buy.

Gilead is mounting a bid to tighten its grip on the HIV market. Having secured approval for twice-yearly HIV prevention product Yeztugo, the company has a shot at wresting more market share from GSK ...

Senator Maggie Hassan is investigating GSK's controversial asthma inhaler switch, alleging the move put the medication out of reach for some patients.